Standout Papers

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA... 2014 2026 2018 2022 1.1k
  1. Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial (2014)
    Éric Pujade-Lauraine, Felix Hilpert et al. Journal of Clinical Oncology

Immediate Impact

5 from Science/Nature 67 standout
Sub-graph 1 of 18

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Cervical cancer therapies: Current challenges and future perspectives
2022 Standout
9 intermediate papers

Works of B. Weber being referenced

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
B. Weber 1873 1565 800 95 3.7k
Roberto Sorio 1613 1645 600 127 3.5k
P. Vasey 1452 1660 954 97 3.7k
Jean Hurteau 1269 1095 640 85 3.1k
Jung‐Yun Lee 1422 1308 693 248 3.8k
Alexander Burges 1861 1221 1374 169 3.9k
Atsuhiko Sakamoto 901 991 635 120 3.4k
Cláudia Marchetti 1455 934 627 168 3.2k
Stefania Cosio 1682 877 741 117 3.3k
Stergios Boussios 901 1741 498 136 3.3k
J. J. Kavanagh 1213 865 734 93 2.9k

All Works

Loading papers...

Rankless by CCL
2026